Investigating the effects of a daily multidisciplinary intensive outpatient rehabilitation program on innovative biomarkers in people with Parkinson's disease: Study protocol for a phase III randomized controlled clinical trial.
<h4>Background</h4>To date, there has been no medication that has prevented the progression of Parkinson's disease (PD). Many benefits of intensive and multidisciplinary rehabilitation program for PD are supported by clinical, epidemiological, and experimental data. The main questio...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0309405 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846165786633175040 |
|---|---|
| author | Francesca Lea Saibene Cristina Agliardi Anna Salvatore Pietro Arcuri Anna Castagna Silvia Gobbo Federico Merlo Thomas Bowman Denise Anastasi Chiara Pagliari Elisabetta Farina Margherita Alberoni Elena Calabrese Francesca La Rosa Chiara Arienti Marina Saresella Franca Rosa Guerini Davide Cattaneo Francesca Baglio Mario Clerici Jorge Navarro Mario Meloni |
| author_facet | Francesca Lea Saibene Cristina Agliardi Anna Salvatore Pietro Arcuri Anna Castagna Silvia Gobbo Federico Merlo Thomas Bowman Denise Anastasi Chiara Pagliari Elisabetta Farina Margherita Alberoni Elena Calabrese Francesca La Rosa Chiara Arienti Marina Saresella Franca Rosa Guerini Davide Cattaneo Francesca Baglio Mario Clerici Jorge Navarro Mario Meloni |
| author_sort | Francesca Lea Saibene |
| collection | DOAJ |
| description | <h4>Background</h4>To date, there has been no medication that has prevented the progression of Parkinson's disease (PD). Many benefits of intensive and multidisciplinary rehabilitation program for PD are supported by clinical, epidemiological, and experimental data. The main question is whether high-intensity motor and cognitive exercises have an effect on the disease's biological mechanisms.<h4>Objective</h4>This study protocol is a Randomized Controlled Trial (RCT) designed to determine the efficacy of an experimental, intensive, and multidisciplinary treatment in comparison to a home-based self-treatment in improving biomolecular and functional parameters in PD.<h4>Methods</h4>A total of 72 participants will be randomly allocated to two different groups, experimental (n = 36) and control group (n = 36). The rehabilitation program will last 6 consecutive weeks and will involve the execution of a total of 30 sessions, one for each day of the week from Monday to Friday. Participants allocated to the control group will carry out a home-based self-treatment program that includes muscle-stretching and active mobilization exercises for 40'/day for 6 consecutive weeks. The primary outcome measure is the effects of both treatments on a new set of molecular biomarkers such as oligomeric alpha-synuclein and neurotrophic factors measured in peripheral neural derived extracellular vesicles (NDEVs). Secondary outcomes will include changes of motor and non-motor symptoms, balance and gait performance and cognitive functioning. This RCT has been registered as "Intensive Multidisciplinary Rehabilitation and Biomarkers in Parkinson's Disease" on 30 May, 2022 to ClinicalTrials.gov with the Study ID number: NCT05452655.<h4>Discussion</h4>This rehabilitation program is believed to be crucial in modifying biomolecular and functional parameters in people with PD. We expect that this study will provide additional evidence to understand the impact of an aerobic and intensive rehabilitation program on brain plasticity in patients with PD. |
| format | Article |
| id | doaj-art-ca46a6b2077e413cb395b9e874804e7a |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-ca46a6b2077e413cb395b9e874804e7a2024-11-17T05:31:17ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-011910e030940510.1371/journal.pone.0309405Investigating the effects of a daily multidisciplinary intensive outpatient rehabilitation program on innovative biomarkers in people with Parkinson's disease: Study protocol for a phase III randomized controlled clinical trial.Francesca Lea SaibeneCristina AgliardiAnna SalvatorePietro ArcuriAnna CastagnaSilvia GobboFederico MerloThomas BowmanDenise AnastasiChiara PagliariElisabetta FarinaMargherita AlberoniElena CalabreseFrancesca La RosaChiara ArientiMarina SaresellaFranca Rosa GueriniDavide CattaneoFrancesca BaglioMario ClericiJorge NavarroMario Meloni<h4>Background</h4>To date, there has been no medication that has prevented the progression of Parkinson's disease (PD). Many benefits of intensive and multidisciplinary rehabilitation program for PD are supported by clinical, epidemiological, and experimental data. The main question is whether high-intensity motor and cognitive exercises have an effect on the disease's biological mechanisms.<h4>Objective</h4>This study protocol is a Randomized Controlled Trial (RCT) designed to determine the efficacy of an experimental, intensive, and multidisciplinary treatment in comparison to a home-based self-treatment in improving biomolecular and functional parameters in PD.<h4>Methods</h4>A total of 72 participants will be randomly allocated to two different groups, experimental (n = 36) and control group (n = 36). The rehabilitation program will last 6 consecutive weeks and will involve the execution of a total of 30 sessions, one for each day of the week from Monday to Friday. Participants allocated to the control group will carry out a home-based self-treatment program that includes muscle-stretching and active mobilization exercises for 40'/day for 6 consecutive weeks. The primary outcome measure is the effects of both treatments on a new set of molecular biomarkers such as oligomeric alpha-synuclein and neurotrophic factors measured in peripheral neural derived extracellular vesicles (NDEVs). Secondary outcomes will include changes of motor and non-motor symptoms, balance and gait performance and cognitive functioning. This RCT has been registered as "Intensive Multidisciplinary Rehabilitation and Biomarkers in Parkinson's Disease" on 30 May, 2022 to ClinicalTrials.gov with the Study ID number: NCT05452655.<h4>Discussion</h4>This rehabilitation program is believed to be crucial in modifying biomolecular and functional parameters in people with PD. We expect that this study will provide additional evidence to understand the impact of an aerobic and intensive rehabilitation program on brain plasticity in patients with PD.https://doi.org/10.1371/journal.pone.0309405 |
| spellingShingle | Francesca Lea Saibene Cristina Agliardi Anna Salvatore Pietro Arcuri Anna Castagna Silvia Gobbo Federico Merlo Thomas Bowman Denise Anastasi Chiara Pagliari Elisabetta Farina Margherita Alberoni Elena Calabrese Francesca La Rosa Chiara Arienti Marina Saresella Franca Rosa Guerini Davide Cattaneo Francesca Baglio Mario Clerici Jorge Navarro Mario Meloni Investigating the effects of a daily multidisciplinary intensive outpatient rehabilitation program on innovative biomarkers in people with Parkinson's disease: Study protocol for a phase III randomized controlled clinical trial. PLoS ONE |
| title | Investigating the effects of a daily multidisciplinary intensive outpatient rehabilitation program on innovative biomarkers in people with Parkinson's disease: Study protocol for a phase III randomized controlled clinical trial. |
| title_full | Investigating the effects of a daily multidisciplinary intensive outpatient rehabilitation program on innovative biomarkers in people with Parkinson's disease: Study protocol for a phase III randomized controlled clinical trial. |
| title_fullStr | Investigating the effects of a daily multidisciplinary intensive outpatient rehabilitation program on innovative biomarkers in people with Parkinson's disease: Study protocol for a phase III randomized controlled clinical trial. |
| title_full_unstemmed | Investigating the effects of a daily multidisciplinary intensive outpatient rehabilitation program on innovative biomarkers in people with Parkinson's disease: Study protocol for a phase III randomized controlled clinical trial. |
| title_short | Investigating the effects of a daily multidisciplinary intensive outpatient rehabilitation program on innovative biomarkers in people with Parkinson's disease: Study protocol for a phase III randomized controlled clinical trial. |
| title_sort | investigating the effects of a daily multidisciplinary intensive outpatient rehabilitation program on innovative biomarkers in people with parkinson s disease study protocol for a phase iii randomized controlled clinical trial |
| url | https://doi.org/10.1371/journal.pone.0309405 |
| work_keys_str_mv | AT francescaleasaibene investigatingtheeffectsofadailymultidisciplinaryintensiveoutpatientrehabilitationprogramoninnovativebiomarkersinpeoplewithparkinsonsdiseasestudyprotocolforaphaseiiirandomizedcontrolledclinicaltrial AT cristinaagliardi investigatingtheeffectsofadailymultidisciplinaryintensiveoutpatientrehabilitationprogramoninnovativebiomarkersinpeoplewithparkinsonsdiseasestudyprotocolforaphaseiiirandomizedcontrolledclinicaltrial AT annasalvatore investigatingtheeffectsofadailymultidisciplinaryintensiveoutpatientrehabilitationprogramoninnovativebiomarkersinpeoplewithparkinsonsdiseasestudyprotocolforaphaseiiirandomizedcontrolledclinicaltrial AT pietroarcuri investigatingtheeffectsofadailymultidisciplinaryintensiveoutpatientrehabilitationprogramoninnovativebiomarkersinpeoplewithparkinsonsdiseasestudyprotocolforaphaseiiirandomizedcontrolledclinicaltrial AT annacastagna investigatingtheeffectsofadailymultidisciplinaryintensiveoutpatientrehabilitationprogramoninnovativebiomarkersinpeoplewithparkinsonsdiseasestudyprotocolforaphaseiiirandomizedcontrolledclinicaltrial AT silviagobbo investigatingtheeffectsofadailymultidisciplinaryintensiveoutpatientrehabilitationprogramoninnovativebiomarkersinpeoplewithparkinsonsdiseasestudyprotocolforaphaseiiirandomizedcontrolledclinicaltrial AT federicomerlo investigatingtheeffectsofadailymultidisciplinaryintensiveoutpatientrehabilitationprogramoninnovativebiomarkersinpeoplewithparkinsonsdiseasestudyprotocolforaphaseiiirandomizedcontrolledclinicaltrial AT thomasbowman investigatingtheeffectsofadailymultidisciplinaryintensiveoutpatientrehabilitationprogramoninnovativebiomarkersinpeoplewithparkinsonsdiseasestudyprotocolforaphaseiiirandomizedcontrolledclinicaltrial AT deniseanastasi investigatingtheeffectsofadailymultidisciplinaryintensiveoutpatientrehabilitationprogramoninnovativebiomarkersinpeoplewithparkinsonsdiseasestudyprotocolforaphaseiiirandomizedcontrolledclinicaltrial AT chiarapagliari investigatingtheeffectsofadailymultidisciplinaryintensiveoutpatientrehabilitationprogramoninnovativebiomarkersinpeoplewithparkinsonsdiseasestudyprotocolforaphaseiiirandomizedcontrolledclinicaltrial AT elisabettafarina investigatingtheeffectsofadailymultidisciplinaryintensiveoutpatientrehabilitationprogramoninnovativebiomarkersinpeoplewithparkinsonsdiseasestudyprotocolforaphaseiiirandomizedcontrolledclinicaltrial AT margheritaalberoni investigatingtheeffectsofadailymultidisciplinaryintensiveoutpatientrehabilitationprogramoninnovativebiomarkersinpeoplewithparkinsonsdiseasestudyprotocolforaphaseiiirandomizedcontrolledclinicaltrial AT elenacalabrese investigatingtheeffectsofadailymultidisciplinaryintensiveoutpatientrehabilitationprogramoninnovativebiomarkersinpeoplewithparkinsonsdiseasestudyprotocolforaphaseiiirandomizedcontrolledclinicaltrial AT francescalarosa investigatingtheeffectsofadailymultidisciplinaryintensiveoutpatientrehabilitationprogramoninnovativebiomarkersinpeoplewithparkinsonsdiseasestudyprotocolforaphaseiiirandomizedcontrolledclinicaltrial AT chiaraarienti investigatingtheeffectsofadailymultidisciplinaryintensiveoutpatientrehabilitationprogramoninnovativebiomarkersinpeoplewithparkinsonsdiseasestudyprotocolforaphaseiiirandomizedcontrolledclinicaltrial AT marinasaresella investigatingtheeffectsofadailymultidisciplinaryintensiveoutpatientrehabilitationprogramoninnovativebiomarkersinpeoplewithparkinsonsdiseasestudyprotocolforaphaseiiirandomizedcontrolledclinicaltrial AT francarosaguerini investigatingtheeffectsofadailymultidisciplinaryintensiveoutpatientrehabilitationprogramoninnovativebiomarkersinpeoplewithparkinsonsdiseasestudyprotocolforaphaseiiirandomizedcontrolledclinicaltrial AT davidecattaneo investigatingtheeffectsofadailymultidisciplinaryintensiveoutpatientrehabilitationprogramoninnovativebiomarkersinpeoplewithparkinsonsdiseasestudyprotocolforaphaseiiirandomizedcontrolledclinicaltrial AT francescabaglio investigatingtheeffectsofadailymultidisciplinaryintensiveoutpatientrehabilitationprogramoninnovativebiomarkersinpeoplewithparkinsonsdiseasestudyprotocolforaphaseiiirandomizedcontrolledclinicaltrial AT marioclerici investigatingtheeffectsofadailymultidisciplinaryintensiveoutpatientrehabilitationprogramoninnovativebiomarkersinpeoplewithparkinsonsdiseasestudyprotocolforaphaseiiirandomizedcontrolledclinicaltrial AT jorgenavarro investigatingtheeffectsofadailymultidisciplinaryintensiveoutpatientrehabilitationprogramoninnovativebiomarkersinpeoplewithparkinsonsdiseasestudyprotocolforaphaseiiirandomizedcontrolledclinicaltrial AT mariomeloni investigatingtheeffectsofadailymultidisciplinaryintensiveoutpatientrehabilitationprogramoninnovativebiomarkersinpeoplewithparkinsonsdiseasestudyprotocolforaphaseiiirandomizedcontrolledclinicaltrial |